Mechanisms of placebo effect and of conditioning: Neurobiological data in human and animals;Mécanismes de l'effet placebo et du conditionnement: Données neurobiologiques chez l'homme et l'animal

Medecine/Sciences

Volumn 21, Issue 3, 2005, Pages 315-319

  Haour, France ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CAFFEINE; DOPAMINE; ENDORPHIN; PLACEBO;

CONDITIONED REFLEX; CONDITIONING; DRUG RESPONSE; EXPECTATION; HUMAN; MEMORY; MENTALISTIC THEORY; NEUROBIOLOGY; NEUROIMAGING; NEUROSCIENCE; NONHUMAN; PARKINSON DISEASE; REVIEW; THEORY;

ANIMALIA;

EID: 15444378503     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005213315     Document Type: Review

References (42)

1. Wolf S. The pharmacology of placebos. Pharmacol Rev 1959; 11: 689-704.
2. Shapiro AK, Shapiro E. The placebo: is it much ado about nothing. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press, 1997: 2-36.
3. Lemoine P. Le mystère du placebo. Paris: Odile Jacob, 1996: 238 p.
4. Beecher HK. The powerful placebo. JAMA 1955; 159: 1602-6.
5. Turner JA, Deyo RA, Loeser JD, et al. The importance of placebo effects in pain treatment and research. JAMA 1994; 271: 1609-14.
6. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344: 1594-602.
7. De la Fuente-Fernandez R, Schulzer M, Jon Stoessl A. The placebo effect in neurological disorders. Lancet Neurol 2002; 1: 85-91.
8. Evans FJ. Expectancy, therapeutic instructions and placebo responses. In: Placebo: theory, research and mechanisms. New York: Guilford Press, 1985: 215-28.
9. Flaten MA, Simonsen T, Olsen H. Drug related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999; 61: 250-5.
10. Kirsch I. Specifying non-specific: psychological mechanism of the placebo effect. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press, 1997: 166-86.
11. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematous. Science 1982; 215: 1534-6.
12. Ader R. The rote of conditioning in pharmacotherapy. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge: Harvard University Press, 1997: 138-65.
13. Enserink M. Can the placebo be the cure? Science 1999; 184: 238-40.
14. Haour F, Marquette C, Ban E, et al. Interleukin-1 receptors in the central nervous system: role in infection and stress. J Psychiatr Neurosci 1995; 20: 357-63.
15. Haour F, Dicou E. Interleukin-1 receptors and ligands in the nervous system. In: Saade NE, et al., eds. Pain and neuroimmune interactions. New York: Kluger Academic-Plenum Publisher, 2000: 157-70.
16. Besedovsky H, Del Rey AE. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrinol Rev 1996; 17: 64-102.
17. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994; 15: 504-11.
18. Pert CB, Ruff MR, Weber RJ, et al. Neuropeptides and their receptors: a psychosomatic network. J Immunol 1985; 135: S820-6.
19. Dunn AJ. Mechanisms by which cytokines signal the brain. Int Rev Neurobiol 2002; 52: 43-65.
20. Goebel MU, Trebst AE, Steiner J, et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002; 16: 1869-73.
21. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293: 1164-6.
22. De la Fuente-Fernandez R, Jon Stoessl A. The placebo effect in Parkinson's disease. Trends Neurosci 2002; 25: 302-6.
23. Kaasinen V, Aalto S, Nägren K, Rinne JO. Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci 2004; 19: 2352-6.
24. Wall PD. The placebo and the placebo response. In: Wall PD, Melzack R, eds. Textbook of pain. New York: Churchill Livingston, 1993: 1297-308.
25. Exton MS, Schult M, Donath S, et al. Behavioral conditionning prolongs heart allograft survival in rats. Transplant Proc 1998; 30: 2033.
26. Exton MS, Schult M, Donath S, et al. Conditionned immunosuppression make subtherapeutic cyclosporine effective via splenic innervation. Am J Physiol 1999; 276: 1710-7.
27. Exton MS, Gierse C, Meier B, et al. Behaviouraly conditioned immunosuppression in the rat is regulated by noradrenaline and beta-adrenoreceptors. J Neuroimmunol 2002; 131: 21-30.
28. Wolf S. Effect of suggestion and conditioning on the action of the chemical agents in human subjects. The pharmacology of placebos. J Clin Invest 1950; 29: 100-9.
29. Stockhorst U, Mahl N, Krueger M, et al. Classical conditioning and conditionability of insulin and glucose effect in healthy humans. Physiol Behav 2004; 81: 375-88.
30. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditionning-activated specific subsystems. J Neurosci 1999; 19: 484-94.
31. Bootzin RR. The role of expectancy in behavior change. In: Placebo, theory, research, and mechanisms. New York: Guilford Press, 1985: 196-210.
32. Petrovic P, Kalso E, Peterson KM, et al. Placebo and opioid analgesia. Imaging a shared neuronal network. Science 2002; 295: 1737-40.
33. Zubieta JK, Smith YR, Bueller JA, et al. Mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293: 311-5.
34. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303: 1162-7.
35. Kirsh I, Sapirstein G. Listening to prozac but hearing placebo. A meta-analysis of antidepressants medication. In: Prevention and treatment, vol. 1. New York: American Psychological Association, 1998. journals.apa.org/ prevention
36. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed subject during treatment with placebo. Am J Psychiatry 2002; 59: 122-9.
37. Mayberg HS, Silva JA, Brannan SK, et al. The functional anatomy of the placebo effect. Am J Psychiatry 2002; 159: 728-37.
38. Jonas WB, Katchup TJ, Linde K. A critical review of homeopathy. Ann Intern Med 2003; 138: 393-459.
39. Rubi P, Decety J. What you believe versus what you think they believe: a neuroimaging study of conceptual perspective-taking. Eur J Neurosci 2004; 17: 2475-80.
40. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbique pathways in major depression: treatment specific effects of cognitive behaviour therapy. Arch Gen Psychiatry 2004; 61: 34-41.
41. Wise RA, Rompre PP. Brain dopamine and reward. Ann Rev Psychol 1989; 40: 191-225.
42. Schultz W. Predictive reward signal of dopamine neurones. J Neurophysiol 1998; 80: 1-27.